Not Yet Recruiting
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
NCT06762925
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
- Locations
-
Not specified